chr10-89433129-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_213606.4(SLC16A12):āc.1486A>Gā(p.Arg496Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_213606.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A12 | NM_213606.4 | c.1486A>G | p.Arg496Gly | missense_variant | 8/8 | ENST00000371790.5 | NP_998771.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A12 | ENST00000371790.5 | c.1486A>G | p.Arg496Gly | missense_variant | 8/8 | 2 | NM_213606.4 | ENSP00000360855.4 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251342Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135836
GnomAD4 exome AF: 0.000168 AC: 246AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.000153 AC XY: 111AN XY: 727242
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.1486A>G (p.R496G) alteration is located in exon 8 (coding exon 6) of the SLC16A12 gene. This alteration results from a A to G substitution at nucleotide position 1486, causing the arginine (R) at amino acid position 496 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
SLC16A12-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2024 | The SLC16A12 c.1486A>G variant is predicted to result in the amino acid substitution p.Arg496Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.023% of alleles in individuals of Latino descent in gnomAD, which is likely too frequent for an unreported disease causing variant. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at